NCT05378321

Prevalence of NAFLD in ACS Patients

The Prevalence of Non-Alcoholic Fatty Liver Disease in Patients With an Acute Cardiac Event Followed at Ziekenhuis Oost-Limburg, Genk, Belgium

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 225 (actual)
• Sponsor: Ziekenhuis Oost-Limburg · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Addressing CVD risk in patients with NAFLD is the aspect of the disease most amenable to medical management and so improving long-term clinical outcomes. Almost no studies have been done concerning the prevalence of NAFLD in CVD patients, most of the conducted studies have been done in already diagnosed NAFLD patients to estimate the risk of CVD development. Currently, there are no data available about the prevalence of NAFLD in CVD, more specifically patients with an acute cardiovascular event (ACE) in Belgium.

Conditions

• NAFLD
• ACS - Acute Coronary Syndrome

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Non-invasive diagnostic testing	Non-invasive diagnostic testing consists of the use of the FibroScan device and the calculation of non-invasive blood-based scores for the diagnosis of NAFLD

Timeline

• Start date: 2022-02-01
• Primary completion: 2025-03-31
• Completion: 2025-03-31
• First posted: 2022-05-18
• Last updated: 2025-07-09

Locations

1 site across 1 country: Belgium